您的购物车当前为空
ER 50891 quarterhydrate为效效的视黄酸受体α(RARα)拮抗剂,可显著削弱ATRA对BMP 2诱导成骨细胞生成的抑制效果。
ER 50891 quarterhydrate为效效的视黄酸受体α(RARα)拮抗剂,可显著削弱ATRA对BMP 2诱导成骨细胞生成的抑制效果。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
ER 50891 quarterhydrate 相关产品
| 产品描述 | ER 50891 quarterhydrate is a potent RARα (retinoic acid receptor α) antagonist that markedly diminishes the inhibitory effects of ATRA (all-trans retinoic acid) on osteoblastogenesis induced by BMP 2 (bone morphogenetic protein 2) [1]. |
| 分子量 | 437.02 |
| 分子式 | C29H24N2O2.1/4H2O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容